In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation

Rosemarie Krupar*, Christian Watermann, Christian Idel, Julika Ribbat-Idel, Anne Offermann, Helen Pasternack, Jutta Kirfel, Andrew G. Sikora, Sven Perner

*Korrespondierende/r Autor/-in für diese Arbeit
1 Zitat (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation“. Zusammen bilden sie einen einzigartigen Fingerprint.

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science